Skip to main content
Premium Trial:

Request an Annual Quote

German Ag-Bio Firm Extends License for Biomax Software

Premium

NEW YORK (GenomeWeb) – Biomax Informatics said this week that KWS SAAT, a German plant breeding company, has extended an existing software license agreement for Biomax's Pedant-Pro Sequence Analysis suite.

Biomax's software has supported the ag-bio firm's activities around functional and structural annotation of plant and fungal-based genomic and cDNA sequences for several years and is a "central component" of its bioinformatics platform, according to Andreas Menze, KWS' head of bioinformatics. "In addition to the Pedant-Pro system’s broad range of functionality and diverse integrated databases, the software has a very user-friendly GUI, which allows even staff with little IT experience to use the system efficiently," he said in a statement.

Financial and other terms of the renewed agreement were not disclosed.

Filed under

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.